Epigenomics dynamically regulates gene expression and thus alters the epigenetic state of genes, which may influence our immune system. CD Genomics provides services to analyze the epigenomics of target samples to help our clients understand the epigenetic impact on the immunomics.
Epigenomics is the study of the complete epigenetic modification of the cellular genetic material, also known as the epigenome. DNA methylation and histone modifications are by far the major epigenetic mechanisms recognized. In addition, microRNAs (miRNAs) are widely recognized as important epigenetic controllers of gene expression.
Fig.1 Major categories of epigenetic
regulation. (Antrobus, M., et al., 2021)
Complex DNA and histone modifications result in changes in the overall conformation and structure of chromatin between a closed inactive state and a loose/open active conformation, thereby affecting gene transcription in the immune pathway. The analysis of epigenomics facilitates the unraveling of the pathogenesis of multiple immune-related diseases.
The immune system is an important barrier of defense against foreign antigens. Therefore, the analysis of epigenetic changes can provide important information for the mechanistic study and treatment of multiple diseases, especially beneficial for the study of autoimmune diseases and tumors.
CD Genomics provides professional epigenomics analysis services in immunomics for clients worldwide. Epigenomics services can be divided into two categories based on the content of the study, which is the chemical modification of DNA/RNA and DNA/RNA-protein interactions. The services we provide, including but not limited to the following three.
Experimental Design
Sample Testing
Library Construction
Sequencing Experiments
Data Analysis
Project Delivery
![]() |
High Sensitivity - Single base resolution for accurate detection of the methylation status of each cytosine. |
![]() |
High Efficiency - Accurate acquisition of whole genome methylation sites and rapid experimentation with multiple samples. |
![]() |
Analysis Capability - Combine multiple technologies to comprehensively analyze the epigenetic status of samples. |
As a pioneer in immunomics, CD Genomics has focused on conducting immune epigenomic studies for many years. Through collaboration and communication with our clients, we resolve bottlenecks in projects and advance mechanistic studies of multiple immune-related diseases. Please contact us for more information.